Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT06228833
Other study ID # SKCRFAGE002
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date January 30, 2024
Est. completion date October 30, 2024

Study information

Verified date January 2024
Source Yes Skin Medical Group
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

A Prospective, Single-center, Single-blind, Randomized split-face, controlled trial will be conducted. The goal of this clinical trial is to evaluate the efficacy and safety of monopolar radiofrequency combined with SkinCeuticals A.G.E and Skinceuticals CE FERULIC for improving facial skin elasticity, tightening and fading fine lines


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 50
Est. completion date October 30, 2024
Est. primary completion date March 30, 2024
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 25 Years to 65 Years
Eligibility Inclusion Criteria: - Subjects must meet all of the following criteria to be enrolled in the study: 1. Healthy women, skin quality is not limited, aged 25 ~ 65 years old face old ~ moderate aging group; 2. subjects facial skin rough, loose, lack of elasticity; 3. Subjects with multiple facial fine lines, decree lines or puppet lines areas have static fine lines trend, the lower part showed signs of loosening; 4. Subjects with consistent facial skin status on both sides and planning to receive monopolar radiofrequency treatment; 5. Be able to cooperate well with the tester and maintain the regularity of life during the study; 6. Be able to read and understand all contents of the informed consent form, and voluntarily sign the informed consent form (ICF); 7. Agreed not to use any cosmetics, drugs and health products that have an impact on the results during the trial; Exclusion Criteria: - Subjects were not included in the study if they met any of the following exclusion criteria: 1. Subjects with contraindications to monopolar radiofrequency treatment (such as malignant tumors, acute systemic infection, metal implants or active implants in the body such as cardiac pacemakers/defibrillators, etc.) or contraindications to A.G.E./CE use (or allergies to other skin care components); 2. Subjects with facial skin diseases, infections, inflammation, etc. that may affect the judgment of the test results; 3. Subjects with hypertrophic scar or scar constitution; 4. Subjects who have experienced tightening medical treatment (Gemma, Fotona 4D, ultrasonic cannon, ultrasonic scalpel, gold microneedle, etc.) in the past 3 months; 5. Subjects who have oral and topical cosmetic products that may affect the study results within 2 weeks; 6. Subjects who participate in drug clinical trials or other trials within 30 days, or subjects who have systemic use of drugs that may affect the study results within the past 1 week; 7. Pregnant or lactating women, or recent plans to prepare for pregnancy; 8. Other subjects who are not suitable for participating in this study as assessed by the investigator.

Study Design


Related Conditions & MeSH terms


Intervention

Device:
monopolar radiofrequency
Each subject underwent monopolar radiofrequency treatment (Thermage FLX ™ ) on both sides of the face
Other:
SkinCeuticals A.G.E and Skinceuticals CE FERULIC
Test Side receives SkinCeuticals A.G.E and Skinceuticals CE FERULIC
Standard Cream
Control Side applies Standard Cream

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Yes Skin Medical Group

Outcome

Type Measure Description Time frame Safety issue
Primary Global aesthetic improvement scale (GAIS) score Investigator Satisfaction Assessment Form. Scoring criteria: 3 (very much improved), 2 (marked improvement), 1 (improved), 0 (no change), or -1 (worse). at day 90 after procedure
Secondary Global aesthetic improvement scale (GAIS) score Investigator Satisfaction Assessment Form. Scoring criteria: 3 (very much improved), 2 (marked improvement), 1 (improved), 0 (no change), or -1 (worse). at 30, 60 days after procedure
Secondary Improvement of skin glossiness Skin glossiness was assessed by an independent investigator on both sides of the face (three measurements averaged) according to DermaLab ® Combo (Multipurpose Skin Detector, Cortex) + Chromaticity Test Probe at 30, 60, 90 days after procedure
Secondary Improvement in skin elasticity and tightness Skin elasticity was assessed by an independent investigator on both sides of the face (averaged over three measurements) according to the DermaLab ® Combo + Elastic Probe at 30, 60, 90 days after procedure
Secondary Improvement in dermal thickness/density Dermal thickness/density was assessed on both sides of the face (averaged over three measurements) by an independent investigator using the DermaLab ® Combo + HF ultrasound probe at 30, 60, 90 days after procedure
Secondary Improvement of transepidermal water loss (TEWL) TEWL was assessed by an independent investigator on both sides of the face (three measurements averaged) according to the DermaLab ® Combo + TEWL test probe at 30, 60, 90 days after procedure
Secondary Improvement of skin stratum corneum water content Skin stratum corneum moisture was assessed on both sides of the face (three measurements averaged) by an independent investigator using the DermaLab ® Combo + Moisture Testing Probe at 30, 60, 90 days after procedure
Secondary Improvement in fine lines score Skin Parameter Assessment Form. Fine lines: Grading was performed on a Griffith 's scale (10-point scale) with different scores representing: 0 (no fine lines/wrinkles, skin completely smooth and no wrinkles); 1-3 (mild, few fine lines and wrinkles, and distant intervals within the treatment area); 4-6 (moderate, moderate number of fine lines/wrinkles within the treatment area and close to each other); and 7-9 (severe, dense clusters of fine lines/wrinkles within the treatment area). Fine lines status should be evaluated by an independent investigator. at 30, 60, 90 days after procedure
Secondary Subject satisfaction evaluation Subject Satisfaction Assessment Form. 1: very dissatisfied, 2: dissatisfied, 3: fair, 4: satisfied, and 5: very satisfied, and the proportion of people in each rating was statistically summarized at 30, 60, 90 days after procedure
See also
  Status Clinical Trial Phase
Completed NCT04276753 - A Randomized, Double-blinded, Placebo Controlled, Monocentric Study to Evaluate the Anti-ageing and Skin Brightening Benefit of the Test Product in Healthy Female Subjects N/A
Completed NCT06125912 - A Comparative Split-Face Study of the Effects of a Retinol Alternative Cream on Improving Facial Skin Aging N/A
Completed NCT02580370 - Safety and Efficacy of Botulinum Toxin Type A Topical Gel for Lateral Canthal Lines Phase 3
Recruiting NCT01583478 - Comparison of Escalating Doses of IncobotulinumtoxinA (Xeomin®) in the Treatment of Glabellar Rhytids Phase 4
Completed NCT02003833 - Poly-L-lactic Acid for Skin Quality Phase 4
Completed NCT01447342 - A Study to Evaluate the Safety and Effectiveness of the Cryo-Touch II Device for the Treatment of Forehead and/or Glabellar Lines Phase 2/Phase 3
Completed NCT00986570 - Clinical Trial to Assess Efficacy, Safety and Tolerability of Botulinum Toxin A (Xeomin®) in Treatment of Expression Wrinkles in the Upper Third of the Face Phase 3
Completed NCT00974480 - Comparison of Redermic, Rejuva-A and Combination of Both Redermic and Rejuva-A in Subjects With Signs of Aging N/A
Completed NCT00272610 - Topical Vitamin A Versus Vehicle Cream in the Treatment of Aged Skin Phase 2
Recruiting NCT03730649 - Effect of Topical Sulforaphane on Skin Aging and With Ultraviolet and Visible Light Exposure Early Phase 1
Completed NCT03312543 - Evaluation of the Efficacy and Tolerance of a Light Therapy Mask on Mild to Moderate Brown Spots and Moderate to Severe Facial Wrinkles N/A
Active, not recruiting NCT05349799 - TEOSYAL RHA® 1 for Neck Lines, Perioral Lines and Smiling Lines N/A
Completed NCT03677258 - Effectiveness and Safety of Collagen Complex COLLOST in Anti-age Therapy N/A
Withdrawn NCT05854628 - The Role of Red Flavonoid in Photoaging N/A
Completed NCT01981980 - Comparison of the Effects of Carboxytherapy and Radiofrequency on Skin Rejuvenation N/A
Not yet recruiting NCT00767156 - Effects of Oral and Topical Sea Buckthorn Oil Treatments on Skin Aging N/A
Recruiting NCT05813054 - Clinical Study to Evaluate the Anti-aging Efficacy of Dermial® N/A
Completed NCT05457491 - Novel Antiaging Regenerative Skin Care Regimen Containing Human Platelet Extract (HPE) Phase 1
Not yet recruiting NCT04485091 - TCA Peel and Photobiomodulation for Hand Rejuvenation Phase 2
Completed NCT01237977 - Efficacy and Safety Study of Botulinum Toxin Type A to Treat Glabellar Lines Phase 3